Physician profile
Jannah Bacchus
NPI 1437505492
$1,097.71
in general payments reported to CMS, 2019-2025
15 companies · $23.46 in 2025
The $23.46 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.00 · 2022: $188 · 2023: $567 · 2024: $299 · 2025: $23.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $889.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $889.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $272.99 | 2023-2024 | Proclaim, Eterna, Ionicrf |
| Treace Medical Concepts, INC. | $235.77 | 2023 | |
| Medtronic, INC. | $105.52 | 2024 | |
| Stryker Corporation | $102.67 | 2022-2024 | Actishield, Anchorage |
| Smith+Nephew, INC. | $85.24 | 2022-2024 | Collagenase Santyl |
| Horizon Therapeutics Plc | $63.74 | 2021-2023 | Krystexxa |
| Organogenesis INC. | $42.74 | 2022-2025 | Apligraf |
| Tactile Systems Technology INC | $30.49 | 2023 | Entre Plus, Flexitouch Plus |
| Melinta Therapeutics, LLC | $25.90 | 2023 | Kimyrsa |
| Amgen INC. | $25.88 | 2024 | Krystexxa |
| Kerecis Limited | $24.22 | 2022 | |
| Orthofix Medical, INC. | $23.74 | 2022 | |
| Integra Lifesciences Corporation | $20.89 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Polynovo North America LLC | $19.38 | 2023 | |
| Lightbody Medical Technologies INC | $18.54 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jannah Bacchus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.